Novartis Wins Bone Drug Injury Suit On Timeliness

Law360, New York (August 31, 2012, 4:07 PM EDT) -- A Rhode Island magistrate judge has held that the court should rule in favor of Novartis Pharmaceuticals Corp. in a suit claiming a now-deceased woman allegedly developed a jaw condition from taking the bone drug Aredia, saying the claims are time-barred.

U.S. Magistrate Judge Lincoln Almond recommended on Aug. 28 that Novartis be granted summary judgment in a suit concerning Massachusetts resident Margaret Patterson, who took Aredia from 2000 to 2006 to treat her osteoporosis and developed osteonecrosis of the jaw as a result, according to...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Patterson et al v. Novartis Pharmaceuticals Corporation


Case Number

1:11-cv-00402

Court

Rhode Island

Nature of Suit

P.I.: Other

Judge

Mary M. Lisi

Date Filed

September 8, 2011

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.